Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: A randomized controlled trial

JAMA

Volumn 285, Issue 1, 2001, Pages 52-59

  Rowe, Peter C ^a   Calkins, Hugh ^a   DeDusk, Karen ^a   McKenzie, Robin ^b   Anand, Ravinder ^c   Sharma, Geetika ^b   Cuccherini, Brenda A ^b   Soto, Norberto ^b   Hohman, Patricia ^b   Snader, Sally ^a   Lucas, Katherine E ^a   Wolff, Mark ^c   Straus, Stephen E ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDROCORTISONE; PLACEBO;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOMATOLOGY; TILT TABLE TEST; TREATMENT OUTCOME; WELLBEING;

EID: 0035798745     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.1.52     Document Type: Article

References (46)

1. Chronic fatigue syndrome: A comprehensive approach to its definition and study
2. A community-based study of chronic fatigue syndrome
3. Functional status in chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals
4. Prognosis in chronic fatigue syndrome: A prospective study on the natural course
5. Orthostatic hypotension and orthostatic tachycardia: Treatment with the "head-up" bed
6. Prospective evaluation of clinical characteristics of orthostatic hypotension
7. Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
8. Relationship between neurally mediated hypotension and the chronic fatigue syndrome
9. Does the chronic fatigue syndrome involve the autonomic nervous system?
10. Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome
11. Delayed orthostatic intolerance
12. Neurally mediated hypotension and autonomic dysfunction measured by heart rate variability during head-up tilt testing in children with chronic fatigue syndrome
13. Orthostatic intolerance in the chronic fatigue syndrome
14. Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia?
15. Chronic orthostatic intolerance: A disorder with discordant cardiac and vascular sympathetic control
16. Orthostatic intolerance in adolescent chronic fatigue syndrome
17. Instantaneous orthostatic hypotension in children and adolescents: A new entity of orthostatic intolerance
18. Acyclovir treatment of the chronic fatigue syndrome: Lack of efficacy in a placebo-controlled trial
19. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial
20. The MOS 36-item short-form health survey (SF-36)
21. An inventory for measuring depression
22. A brief mental fatigue questionnaire
23. A brief self-administered questionnaire to determine functional capacity: The Duke Activity Status Index
24. Methodology of isoproterenol-tilt table testing in patients with syncope
25. Postural orthostatic tachycardia syndrome: A neurocardiogenic variant identified during head-up tilt table testing
26. Certain cardiovascular indices predict syncope in the postural tachycardia syndrome
27. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome
28. Low-dose hydrocortisone in chronic fatigue syndrome: A randomised crossover trial
29. Successful treatment of orthostatic hypotension with 9-alpha fluorohydrocortisone
30. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
31. The use of head-up tilt table testing in the evaluation and management of syncope in children and adolescents
32. Neurocardiogenic syncope in children with a normal heart
33. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope
34. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results
35. Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope
36. Midodrine: A role in the management of neurocardiogenic syncope
37. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, for refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study
38. Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: An overview of classification, clinical evaluation, and management
39. Management of vasovagal syncope
40. Panel consensus - Putting it together: A new treatment algorithm for vasovagal syncope and related disorders
41. Physical manoeuvres that reduce postural hypotension in autonomic failure
42. Cardiovascular response during head-up tilt in chronic fatigue syndrome
43. Patterns of orthostatic intolerance: The orthostatic tachycardia syndrome and adolescent chronic fatigue
44. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome